Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Spotify Technology — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B), while Spotify Technology trades at $526.49 (market cap $105.45B). The key difference: Spotify Technology is far larger — about 46.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals.
| SLS | SPOT | |
|---|---|---|
Market Cap | $2.28B | $105.45B |
Volume | 3,128,960 | 2,000,851 |
Sector | Health | Media |
52-Week High | $15.46 | $692.04 |
52-Week Low | $1.39 | $412.75 |
Enterprise Value | $2.15B | $95.41B |
Typical Hold Time | — | 111 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Spotify (SPOT) trades at $526.42, up 7.84% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $15.7B to $17.2B in 2025 and net income surging to $2.2B. Recent Q2 2026 earnings missed expectations, but analyst consensus remains strongly bullish with a $610 price target. Technical indicators show support at $497 and resistance at $524, with the stock approaching key resistance levels.
Spotify presents a compelling growth story with expanding profit margins and strong cash flow generation. The primary investment opportunity lies in continued subscriber growth and margin expansion, though risks include competitive pressures in streaming and execution challenges. Wall Street maintains strong conviction with 62% buy ratings, suggesting 16% upside to consensus targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
